Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SPGI vs GSK✓SelectedUSD · GSKSPGI vs GSK performance historyLatest closeAs of-0.83%11/19
Stock and ETF performance explorer

SPGI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+321.2%
GSK return
+97.7%
Excess return
+223.5%
Maximum drawdown
-39.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.8%-1.6%+0.7%-0.3%
7D-5.5%-4.7%-0.8%-3.8%
30D+1.0%-4.7%+5.7%+2.7%
3M+4.0%-8.8%+12.7%+7.3%
6M+14.5%-4.6%+19.2%+15.9%
YTD-9.8%+1.0%-10.8%-11.8%
1Y-3.8%+6.9%-10.7%-8.0%
3Y+17.5%+52.5%-35.1%-7.4%
5Y+5.8%+40.3%-34.5%-15.0%
All+321.2%+97.7%+223.5%+179.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling